The forecast for the R&D budget for Health and Society in the US indicates a steady increase from 2024 to 2028, with values rising from 40.91 to 42.58 billion US dollars PPP. Comparatively, in 2023, this budget stood at 40.50 billion, marking a continuous upward trend in the funding. The year-on-year growth ranges marginally around 1.05% to 1.02% across these years, which indicates a positive but stable growth rate. The compound annual growth rate (CAGR) from 2023 to 2028 is calculated to be consistent at approximately 1.02% annually.
Future trends to monitor include changes in government policy and funding priorities, potential economic fluctuations, and technological advancements, all of which could impact the R&D budget allocations. Increasing focus on AI and precision medicine might channel more funds into innovative health tech sectors.
